Cisplatin Versus Cisplatin Plus Doxorubicin for Standard-Risk Hepatoblastoma
New England Journal of Medicine - United States
doi 10.1056/nejmoa0810613
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 22, 2009
Authors
Publisher
Massachusetts Medical Society